- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Danila R, Livadariu R, Branisteanu D
Calcitonin Revisited in 2020
Acta Endo (Buc) 2019, 15 (4): 544-548doi: 10.4183/aeb.2019.544
Calcitonin (CT) is a polypeptidic hormone
specifically secreted by the thyroid parafollicular cells (C
cells) and tangentially involved in human phosphocalcic
and bone metabolism. CT from other species (e.g. salmon)
is more potent than human CT and has limited therapeutic
applications. The neoplastic proliferation of C cells
leads to medullary thyroid carcinoma (MTC) generally
characterized by an increase of CT secretion. Serum CT
is therefore the ideal marker for MTC and can confirm its
presence at an early stage, as well as the follow up of its
remission or progression/relapse/survival after surgery.
There are, however, controversies such as the necessity of
CT screening in patients with thyroid nodules, or particular
situations causing false positive or false negative results.
Our minireview also deals with an up-to-date of surgical
procedures for MTC, as well as with non-surgical therapy.
Keywords: calcitonin, thyroid, medullary carcinoma, therapy.
Correspondence: Roxana Livadariu MD, “Grigore T Popa” University of Medicine and Pharmacy, Faculty of Medicine, Surgery, 16
Universitatii St., 700115 Ia?i, România, E-mail: roxanalivadariu@yahoo.com